Last update Feb. 12, 2020
Multiple sclerosis (MS) affects 3 times more women than men during reproductive age (Bove 2016).
The longer breastfeeding lasts, the lower the risk of the mother developing multiple sclerosis (Langer 2017). Lower frequency of the disease has been observed in countries with higher frequency of breastfeeding (Dick 1976).
After pregnancy, there are more relapses in the first postpartum months (Fabian 2016).
For some authors, exclusive breastfeeding in women with MS lowers the risk of postpartum relapse (Langer 2017, Fabian 2016, Hellwig 2015 and 2012), while for others there is no link (Jesus 2017).
Not having been breastfed is associated with an increased risk of MS in pediatric age (Brenton 2017).
Mothers affected by MS need more breastfeeding support as they have been found to breastfeed less (Yalcin 2017).
Breastfeeding should be encouraged in patients with multiple sclerosis (Almas 2016, Hellwig 2015 and 2012,Lawrence 2013).
MS patients have increased levels of prolactin (Wei 2017).
Several medications used to treat MS are comptible with breastfeeding (Almas 2016, Hellwig 2012).
Corticosteroids are a safe therapeutic option during breastfeeding (Alroughani 2016).
Some authors advise a waiting period that varies between 4 hours (Alroughani 2016, Ost 1985), 8 hours (Strijbos 2015) and 24 hours (Houtchens 2013) to breastfeed after a corticosteroid megadose (Smets 2017).
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.